2024-02-13 21:09:02 ET
QuidelOrtho Corporation (QDEL)
Q4 2023 Earnings Conference Call
February 13, 2024 05:00 PM ET
Company Participants
Juliet Cunningham - VP, IR
Douglas Bryant - President & CEO
Joseph Busky - CFO
Conference Call Participants
Andrew Brackmann - William Blair
Alex Nowak - Craig-Hallum
Casey Woodring - JPMorgan
Jack Meehan - Nephron Research
Conor McNamara - RBC
Andrew Cooper - Raymond James
Patrick Donnelly - Citi
John Sourbeer - UBS
Presentation
Operator
Welcome to the QuidelOrtho Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. For those of you participating on the conference call, there will be an opportunity for your questions at the end of today's prepared remarks. Please note that this conference call is being recorded. An audio replay of the conference call will be available on the company's website shortly after this call.
I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations.
Juliet Cunningham
Thank you. Good afternoon, everyone, and thanks for joining QuidelOrtho (ph) fourth quarter and full year financial results conference call. With me today are Doug Bryant, President and CEO; and Joe Busky, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website, and a version of today's presentation can be downloaded there.
Before we begin, I will cover our safe harbor statement. The statements we will make during this call that are not strictly historical, including the company's expectations, plans, future performance and prospects are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to a number of risks and uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors identified under Risk Factors in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023, and subsequent reports filed with the SEC.
Please refer to our SEC filings for a more detailed discussion of forward-looking statements and the risks and uncertainties. We cannot assure you that the forward-looking statements we make or are implied by our statements will be realized. Furthermore, such forward-looking statements represent management's judgment and expectations as of today. Except as required by law, we undertake no obligation to update any forward-looking statement or any time-sensitive information to reflect future events, developments, or changed circumstances for any other reason....
Read the full article on Seeking Alpha
For further details see:
QuidelOrtho Corporation (QDEL) Q4 2023 Earnings Call Transcript